Investigations into the aberrant expression of miR-155, Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS), and cAMP Response Element-Binding Protein (CREB) in AML patients have provided valuable insights into the molecular landscape of this blood cancer 42. This evidence concerns the gene KRAS and acute myeloid leukemia.